{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T12:36:11Z","timestamp":1719059771279},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/wno.0b013e318255b513","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T06:35:30Z","timestamp":1335854130000},"page":"99-101","source":"Crossref","is-referenced-by-count":3,"title":["MS and NMO"],"prefix":"10.1097","volume":"32","author":[{"given":"Galetta","family":"Steven L.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210126","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"R2-1-20210126","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview.","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol"},{"key":"R3-1-20210126","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"R4-1-20210126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2011.02.018","article-title":"Neuromyelitis optica and astrocytic damage in its pathogenesis.","volume":"306","author":"Fujihara","year":"2011","journal-title":"J Neurol Sci"},{"key":"R5-1-20210126","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/WNO.0b013e31825662f1","article-title":"Neuromyelitis optica.","volume":"32","author":"Morrow","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"R6-1-20210126","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNO.0b013e31823c9b6c","article-title":"Relationship between NMO-antibody and anti-MOG antibody in optic neuritis.","volume":"32","author":"Kezuka","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"R7-1-20210126","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/WNO.0b013e31823a9ebc","article-title":"Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis.","volume":"32","author":"Fernandes","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"R8-1-20210126","first-page":"XX","article-title":"Homonymous hemimacular thinning: a unique presentation of optic tract injury in neuromyelitis optica.","volume":"XX","author":"Romero","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"R9-1-20210126","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","article-title":"Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.","volume":"73","author":"Ratchford","year":"2009","journal-title":"Neurology"},{"key":"R10-1-20210126","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devics syndrome).","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"R11-1-20210126","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2006.06.060","article-title":"Natural history of the visual impairment of relapsing neuromyelitis optica.","volume":"114","author":"Merle","year":"2007","journal-title":"Ophthalmology"},{"key":"R12-1-20210126","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","article-title":"Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial.","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"R13-1-20210126","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/WNO.0b013e3181f8a693","article-title":"Neuromyelitis optica antibodies in patients with severe optic neuritis in China.","volume":"31","author":"Lai","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"R14-1-20210126","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis.","volume":"70","author":"Matiello","year":"2008","journal-title":"Neurology"},{"key":"R15-1-20210126","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2010.07.011","article-title":"Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis.","volume":"298","author":"Jarius","year":"2010","journal-title":"J Neurol Sci"},{"key":"R16-1-20210126","first-page":"376","article-title":"Should most patients with optic neuritis be tested for neuromyelitis optica antibodies and should this affect their treatment J Neuroophthalmol.","volume":"30","author":"Galetta","year":"2010","journal-title":""},{"key":"R17-1-20210126","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jns.2006.10.008","article-title":"Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.","volume":"252","author":"Warabi","year":"2007","journal-title":"J Neurol Sci"},{"key":"R18-1-20210126","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/WNL.0b013e3181f8832e","article-title":"IFN beta-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.","volume":"75","author":"Shimizu","year":"2010","journal-title":"Neurology"},{"key":"R19-1-20210126","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","article-title":"Devics neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine.","volume":"51","author":"Mandler","year":"1998","journal-title":"Neurology"},{"key":"R20-1-20210126","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","article-title":"Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.","volume":"66","author":"Jacob","year":"2009","journal-title":"Arch Neurol"},{"key":"R21-1-20210126","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica.","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"key":"R22-1-20210126","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","article-title":"Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.","volume":"65","author":"Jacob","year":"2008","journal-title":"Arch Neurol"},{"key":"R23-1-20210126","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1212\/WNL.0b013e31822a2780","article-title":"Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.","volume":"77","author":"Costanzi","year":"2011","journal-title":"Neurology"},{"key":"R24-1-20210126","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"R25-1-20210126","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1196\/annals.1444.002","article-title":"Neuromyelitis optica and Asian phenotype of multiple sclerosis.","volume":"1142","author":"Kira","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R26-1-20210126","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3181d31e35","article-title":"Neuromyelitis optica in France: a multicenter study of 125 patients.","volume":"74","author":"Collongues","year":"2010","journal-title":"Neurology"},{"key":"R27-1-20210126","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0607242103","article-title":"Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.","volume":"50","author":"Zhou","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-1-20210126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJMoa022328","article-title":"Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.","volume":"349","author":"Berger","year":"2003","journal-title":"N Engl J Med"},{"key":"R29-1-20210126","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1212\/01.WNL.0000127615.15768.AE","article-title":"Similar low frequency of anti-MOG IgG and IgM in MS patients and healthy subjects.","volume":"62","author":"Lampasona","year":"2004","journal-title":"Neurology"},{"key":"R30-1-20210126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","article-title":"Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.","volume":"138","author":"Di Pauli","year":"2011","journal-title":"Clin Immunol"},{"key":"R31-1-20210126","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/intimm\/dxh056","article-title":"Anti MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.","volume":"16","author":"Mantegazza","year":"2004","journal-title":"Int Immunol"},{"key":"R32-1-20210126","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrneurol.2011.45","article-title":"Roles of anti MOG antibodies in demyelination diseases.","volume":"7","author":"Olsson","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"R33-1-20210126","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2006.06.028","article-title":"Antibodies as biological markers for pathophysiological processes in MS.","volume":"180","author":"Reindl","year":"2006","journal-title":"J Neuroimmunol"},{"key":"R35-1-20210126","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ana.22657","article-title":"Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.","volume":"71","author":"Tradtrantip","year":"2012","journal-title":"Ann Neurol"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNO.0b013e318255b513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:43:29Z","timestamp":1620978209000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041327-201206000-00001"}},"subtitle":["Partners No More"],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e318255b513","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}